prostate cancer

Cancer that occurs in the prostate is one of the most common cancers found in men globally. It is also clinically one of the most varied, with a subgroup of patients that advance more quickly to metastasis. Unfortunately, many diagnostic measures used today are not capable of predicting prostate cancer’s (PC) progression. Because epigenetic modifications are usually found early in tumor development, researchers have become more interested in studying these changes to find biomarkers for the disease. In a recent [more…]